Santa Ana, California-based Prophet Premium Blends is recalling all Diamond Shruumz Products, according to the U.S. Food and Drug Administration. These products contain Muscimol, a chemical found in mushrooms of the genus Amanita.
All lots or best buy dates and all flavors of Diamond Shruumz Infused Cones, Chocolate Bars, and Gummies (Micro- and Mega/Extreme-Dose) are included in the recall.
The impacted products were distributed nationwide through retail stores and mail orders.
The agency noted that Muscimol could be a potential cause of symptoms consistent with those observed in persons who became ill after eating Diamond Shruumz products.
Reported symptoms include seizures, agitation, involuntary muscle contractions, loss of consciousness, confusion, sleepiness, nausea and vomiting, abnormal heart rates, and hyper/hypotension.
The recall was initiated after reports of 39 illnesses so far from states including AL, AZ, CA, CO, GA, IN, IA, KY, MD, MN, MO, MT NV, NJ, NY, NC, OH, PA, SC, TN.
To date, Prophet Premium Blends received two complaints on May 27, regarding consumers becoming ill after consuming the entire chocolate bar.
The products' Certificates of Analysis or COAs showed higher than normal amounts of Muscimol. Prophet Premium Blends has now ceased the production and distribution of the Diamond Shruumz product line as the FDA and the firm continue their investigation as to find the cause of the serious adverse effects.
Retailers and wholesalers are urged to discontinue use, stop distribution, quarantine the product immediately and contact their sales representative to initiate the return and refund.
Consumers who have purchased Diamond Shruumz products are also urged to stop using the product, and contact the firm for a refund.
For More Such Health News, visit rttnews.com
For comments and feedback contact: editorial@rttnews.com
Business News
June 12, 2026 17:14 ET Major central bank action was the focus this week in economic news. The European Central Bank became the first major central bank to move in response to the rising inflationary pressures in the backdrop of the conflict in the Middle East. In North America, the U.S. inflation and trade data as well as Canada’s central bank decision gained attention. The Chinese trade data was the main news in Asia.